Reuters logo
BRIEF-GSK still in talks with AstraZeneca about start date for Luke Miels
April 26, 2017 / 2:27 PM / 5 months ago

BRIEF-GSK still in talks with AstraZeneca about start date for Luke Miels

April 26 (Reuters) - GlaxoSmithKline Plc CEO Emma Walmsley told analysts:

* “no comment” on whether would launch authorised advair generic in u.s.

* still in discussion with AstraZeneca about date for Luke Miels to join GSK Further company coverage: (Reporting by UK bureau)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below